KeyBanc Capital Markets analysts initates an Overweight rating for Encompass Health Corp (EHC)

In a filing, Encompass Health Corp revealed its President & CEO Tarr Mark J unloaded Company’s shares for reported $14.39 million on May 20 ’25. In the deal valued at $121.53 per share,118,384 shares were sold. As a result of this transaction, Tarr Mark J now holds 527,070 shares worth roughly $63.36 million.

Then, Mark Tarr bought 118,384 shares, generating $14,383,656 in total proceeds.

Before that, Charbonneau Elissa Joy sold 4,279 shares. Encompass Health Corp shares valued at $498,974 were divested by the Chief Medical Officer at a price of $116.61 per share. As a result of the transaction, Charbonneau Elissa Joy now holds 11,958 shares, worth roughly $1.44 million.

KeyBanc Capital Markets initiated its Encompass Health Corp [EHC] rating to an Overweight in a research note published on October 11, 2024; the price target was $115. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. Barclays began covering EHC with “an Overweight” recommendation on March 06, 2024. Barclays started covering the stock on March 14, 2023. It rated EHC as “an Equal weight”.

Price Performance Review of EHC

On Monday, Encompass Health Corp [NYSE:EHC] saw its stock jump 0.87%% to $120.22. Over the last five days, the stock has lost -0.58%. Encompass Health Corp shares have risen nearly 40.84% since the year began. Nevertheless, the stocks have risen 30.18% over the past one year. While a 52-week high of $123.13 was reached on 06/04/25, a 52-week low of $82.74 was recorded on 01/03/25.

Levels Of Support And Resistance For EHC Stock

The 24-hour chart illustrates a support level at 119.20, which if violated will result in even more drops to 118.19. On the upside, there is a resistance level at 120.82. A further resistance level may holdings at 121.43.

How much short interest is there in Encompass Health Corp?

A steep rise in short interest was recorded in Encompass Health Corp stocks on 2025-05-30, dropping by -1.0 million shares to a total of 0.88 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 1.88 million shares. There was a decline of -114.16%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on September 24, 2021 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $98 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.